<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Harms and Company Consulting &#187; Commercialization</title>
	<atom:link href="http://harmsandcompany.com/main/category/commercialization/feed/" rel="self" type="application/rss+xml" />
	<link>http://harmsandcompany.com/main</link>
	<description>Western Canada grant writing consultant</description>
	<lastBuildDate>Tue, 17 Aug 2010 15:22:34 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Precard announces T-Gap funding for start-ups</title>
		<link>http://harmsandcompany.com/main/2009/08/04/precard-announces-t-gap-funding-for-start-ups/</link>
		<comments>http://harmsandcompany.com/main/2009/08/04/precard-announces-t-gap-funding-for-start-ups/#comments</comments>
		<pubDate>Tue, 04 Aug 2009 15:33:12 +0000</pubDate>
		<dc:creator>Diane Harms</dc:creator>
				<category><![CDATA[Commercialization]]></category>
		<category><![CDATA[Research Funding News]]></category>
		<category><![CDATA[Start-up Companies]]></category>

		<guid isPermaLink="false">http://harmsandcompany.com/main/?p=674</guid>
		<description><![CDATA[Precarn Incorporated announced a new round of funding for the Industrial T-Gap program on July 14th. The Technology-Gap Assistance Program (T-Gap) is geared towards helping companies working in intelligent systems commercialize their technologies. 
Small companies (2-10 employees) can access up to $75,000 (or 65% of project costs) from Precarn for short term (6 month) projects. [...]]]></description>
		<wfw:commentRss>http://harmsandcompany.com/main/2009/08/04/precard-announces-t-gap-funding-for-start-ups/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Business plan summer</title>
		<link>http://harmsandcompany.com/main/2009/07/23/business-plan-summer/</link>
		<comments>http://harmsandcompany.com/main/2009/07/23/business-plan-summer/#comments</comments>
		<pubDate>Thu, 23 Jul 2009 16:10:57 +0000</pubDate>
		<dc:creator>Diane Harms</dc:creator>
				<category><![CDATA[Business Plan]]></category>
		<category><![CDATA[Commercialization]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Venture capital]]></category>

		<guid isPermaLink="false">http://harmsandcompany.com/main/?p=668</guid>
		<description><![CDATA[With grant deadlines, business plans and (a little bit) of summer vacation, blogging has not been on the priority list. While I haven&#8217;t been posting, I have been reading many different blogs.
Over the past few months, I have been working with a few different start-up companies to develop their business plans. Business planning can be [...]]]></description>
		<wfw:commentRss>http://harmsandcompany.com/main/2009/07/23/business-plan-summer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>No really, tech transfer isn&#8217;t dead!</title>
		<link>http://harmsandcompany.com/main/2009/05/27/no-really-tech-transfer-isnt-dead/</link>
		<comments>http://harmsandcompany.com/main/2009/05/27/no-really-tech-transfer-isnt-dead/#comments</comments>
		<pubDate>Thu, 28 May 2009 03:47:48 +0000</pubDate>
		<dc:creator>Diane Harms</dc:creator>
				<category><![CDATA[Commercialization]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Research Politics]]></category>

		<guid isPermaLink="false">http://harmsandcompany.com/main/?p=655</guid>
		<description><![CDATA[In a recent post, I offered a full text version of Marcel Mongeon’s opinion piece from Research Money on the current challenges facing technology transfer in Canada. Technology Transfer Tactics, a monthly newsletter/ezine for technology transfer professionals, posted a commentary on Marcel’s piece on their blog.  In my opinion, they completely sensationalized what Marcel [...]]]></description>
		<wfw:commentRss>http://harmsandcompany.com/main/2009/05/27/no-really-tech-transfer-isnt-dead/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Read about Cdn Venture Capital here:</title>
		<link>http://harmsandcompany.com/main/2009/05/27/read-about-cdn-venture-capital-here/</link>
		<comments>http://harmsandcompany.com/main/2009/05/27/read-about-cdn-venture-capital-here/#comments</comments>
		<pubDate>Wed, 27 May 2009 17:08:53 +0000</pubDate>
		<dc:creator>Diane Harms</dc:creator>
				<category><![CDATA[Commercialization]]></category>
		<category><![CDATA[Venture capital]]></category>

		<guid isPermaLink="false">http://harmsandcompany.com/main/?p=649</guid>
		<description><![CDATA[Chris Arsenault just posted a refreshingly optimistic post on the Canadian venture capital industry here.
Chris&#8217; blog (and his twitter) are really worth following especially if you are interested in learning about Canadian vc activity and issues of interest to Canadian technology entrepreneurs.
His current post hits a little close to home (in a good way) because [...]]]></description>
		<wfw:commentRss>http://harmsandcompany.com/main/2009/05/27/read-about-cdn-venture-capital-here/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tech Transfer is Dead!</title>
		<link>http://harmsandcompany.com/main/2009/05/20/tech-transfer-is-dead/</link>
		<comments>http://harmsandcompany.com/main/2009/05/20/tech-transfer-is-dead/#comments</comments>
		<pubDate>Wed, 20 May 2009 14:48:06 +0000</pubDate>
		<dc:creator>Diane Harms</dc:creator>
				<category><![CDATA[Commercialization]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Research Funding News]]></category>
		<category><![CDATA[Research Politics]]></category>

		<guid isPermaLink="false">http://harmsandcompany.com/main/?p=625</guid>
		<description><![CDATA[Today&#8217;s issue of Research Money (Volume 23; Number &#56) has an op-ed piece written by Marcel Mongeon, a Canadian thought leader in technology transfer and commercialization issues. Marcel&#8217;s commentary is spot-on with my position on technology transfer and academic research. 
Recent discussions about the STIC report and Gordon&#8217;s paper on the economics of peer review [...]]]></description>
		<wfw:commentRss>http://harmsandcompany.com/main/2009/05/20/tech-transfer-is-dead/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
	</channel>
</rss>
